SanazMemarzadehMDPhD

Obstetrics & Gynecology • Los Angeles, CA

Gynecologic Oncology

Professor, Gynecologic Oncologist Obstetrics & Gynecology, UCLA School of Medicine Director of the G.O. Discovery Laboratory

Join to view full profile

Dr. Memarzadeh is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Memarzadeh's full profile

Already have an account?

Office
UCLA Medical Center
10833 Le Conte Avenue, 27-139 CHS
Los Angeles, CA 90095
Phone+1 310-794-7274

Fax+1 310-794-7274

Education & Training

University of California Los AngelesPh.D., Molecular Biology, 2003 - 2008
UCLA David Geffen School of Medicine/UCLA Medical CenterFellowship, Gynecologic Oncology, 2000 - 2003
UCLA David Geffen School of Medicine/UCLA Medical CenterResidency, Obstetrics and Gynecology, 1996 - 2000
University of Pittsburgh School of MedicineClass of 1996

Certifications & Licensure

CA State Medical License 1998 - 2026
American Board of Obstetrics and Gynecology Obstetrics & Gynecology
American Board of Obstetrics and Gynecology Gynecologic Oncology

Awards, Honors, & Recognition

Super Doctors of Southern California Super Doctors, 2020-2023
Los Angeles Top Doctors Top Doctors, 2018, 2020-2023
Alpha omega alpha
Los Angeles City Council recognition for commitment to ovarian cancer research Los Angeles City Council, 2017
APGO Excellence in Teaching Award APGO, 2014
CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
Most Compassionate Doctor American Registry
Join now to see all

Clinical Trials

Study of Mirvetuximab Soravtansine in Combination With Bevacizumab, Carboplatin, Pegylated Liposomal Doxorubicin, Pembrolizumab, or Bevacizumab + Carboplatin in Participants With Folate Receptor Alpha (FRα) Positive Advanced Epithelial Ovarian Cancer, Primary Peritoneal, or Fallopian Tube Cancer Start of enrollment: 2016 Mar 02
Completed
Phase 1, Phase 2
A Study of Niraparib (GSK3985771) Maintenance Treatment in Participants With Advanced Ovarian Cancer Following Response on Front-Line Platinum-Based Chemotherapy Start of enrollment: 2016 Jul 11
Active, not recruiting
Phase 3
A Study in Ovarian Cancer Patients Evaluating Rucaparib and Nivolumab as Maintenance Treatment Following Response to Front-Line Platinum-Based Chemotherapy Start of enrollment: 2018 May 14
Active, not recruiting
Phase 3

Publications & Presentations

PubMed

6 citations
Image-Guided Percutaneous Thermal Ablation of Oligometastatic Ovarian and Non-Ovarian Gynecologic Tumors.
Frank Yuan, Sindy H. Wei, Gottfried E. Konecny, Sanaz Memarzadeh, Robert D. Suh
Journal of Vascular and Interventional Radiology. 2021-02-16
72 citations
Targeting monoamine oxidase A-regulated tumor-associated macrophage polarization for cancer immunotherapy.
Yu-Chen Wang, Xi Wang, Jiaji Yu, Feiyang Ma, Zhe Li
Nature Communications. 2021-06-10
5 citations
Expression of Stromal Progesterone Receptor and Differential Methylation Patterns in the Endometrium May Correlate with Response to Progesterone Therapy in Endometrial...
Adam Neal, Miguel Nunez, Tiffany S. Lai, Anela Tosevska, Marco Morselli
Reproductive Sciences. 2020-03-02

Lectures

Impact of Genetics on Personalizing Treatment of Gynecologic Cancers
9/5/2019
What are the signs of ovarian cancer?
UCLA - 9/25/2018
Ovarian Cancer: What You Need to Know
UCLA - 9/20/2018
Ovarian Cancer: Standard of Care and Beyond
UCLA - 5/1/2018
Endometrial Cancer Care
UCLA - 9/17/2014
Join now to see all

Other

Uterine sarcoma: Classification, clinical manifestations, and diagnosis
Memarzadeh S, Mundt AJ, Berek JS
http://www.uptodate.com/contents/uterine-sarcoma-classification-clinical-manifestations-and-diagnosi
UpToDate, Wolters Kluwer Health - 2013-04-10

Press Mentions

UCLA Scientists Receive $17.4 Million in CIRM Grants to Advance Novel Stem-Cell Based TreatmentsMay 30th, 2024
Common Causes of Sudden, Unexplained Weight GainSeptember 24th, 2020
10 Times Your Weight Gain Might Signal A Big Health ProblemAugust 21st, 2019
Join now to see all

Committees

Member, National Institute of Health, Mechanisms of Cancer Therapeutics A Study Section

Other Languages

Farsi, Spanish

External Links

UCLA profilehttp://www.uclahealth.org/SanazMemarzadeh
GO Discovery Labhttps://www.godiscoverylab.com
Jonsson Comprehensive Cancer Centerhttps://cancer.ucla.edu/research/find-become-a-member/member-directory?id=417